Based on 5 analysts giving stock ratings to Pulse Biosciences Inc in the past month.
In the current month, PLSE has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. PLSE average Analyst price target in the last month is 50.800.
Based on analysts' estimates, PLSE EPS is projected to reach -0.370 in FY2026Q3, following reported EPS of -0.356 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -0.36, while Pulse Biosciences IncPLSE's earnings per share (EPS) for the previous quarter was USD -0.27. EPS for the next quarter is expected at USD -0.37.